Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: Infection or colonisation?;PCR Pneumocystis jirovecii positive chez les patients atteints de maladie auto-immune : Pneumocystose pulmonaire ou simple colonisation ?

Revue de Medecine Interne

Volumn 31, Issue 3, 2010, Pages 194-199

  Mekinian, A ^a   Queyrel, V ^b   Durand Joly, I ^a   Moranne, O ^a   Denis, G ^a   Delhaes, L ^a   Morell Dubois, S ^a   Lambert, M ^a   Launay, D ^a   Hachulla, E ^a   Hatron, P Y ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Biological diagnosis; Connective tissue disease; PCR; Pneumocystis jirovecii

Indexed keywords

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; DIAGNOSTIC VALUE; FEMALE; FUNGAL COLONIZATION; FUNGAL DETECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; SYSTEMIC DISEASE; COMPARATIVE STUDY; COMPLICATION; CONNECTIVE TISSUE DISEASES; DIFFERENTIAL DIAGNOSIS; ISOLATION AND PURIFICATION; LUNG LAVAGE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77249115121     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.11.007     Document Type: Article

References (19)

1. Gajdusek D.C. Pneumocystis carinii: etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19 (1957) 543-565
2. Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100 (1984) 663-671
3. Monnet X., Vidal-Petiot E., Osman D., Hamzaoui O., Durrbach A., Goujard C., et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 12 (2008) 1-10
4. Durand-Joly I., Chabé M., Soula F., Delhaes L., Camus D., and Dei-Cas E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol 45 (2005) 405-410
5. Morris A., Wei K., Afshar K., and Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 197 (2008) 10-17
6. Nevez G., Magois E., Duwat H., Gouilleux V., Jounieaux V., and Totet A. Apparent absence of Pneumocystis jirovecii in healthy subjects. Clin Infect Dis 42 (2006) 99-101
7. Wakefield A.E., Pixley F.J., Banerji S., Sinclair K., Miller R.F., Moxon E.R., et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 336 (1990) 451-453
8. Durand-Joly I., Aliouat E.M., Recourt C., François N., Wauquier M., Camus D., et al. Human-derived Pneumocystis is not infectious to SCID mice. J Clin Microbiol 40 (2002) 1862-1865
9. Robberts F., Liebowitz L.D., and Chalkley L.J. Polymerase chain reaction detection of Pneumocystis jirovecii: evaluation of 9 assays. Diagn Microbiol Infect Dis 58 (2007) 385-392
10. Saito K., Nakayamada S., Nakano K., Tokunaga M., Tsujimura S., Nakatsuka K., et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: reevaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology 43 (2004) 479-485
11. Godeau B., Coutant-Perrone V., Le Thi Huong D., Guillevin L., Magadur G., De Bandt M., et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21 (1994) 246-251
12. Ognibene F.P., Shelhamer J.H., Hoffman G.S., Kerr G.S., Reda D., Fauci A.S., et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 151 (1995) 795-799
13. Jarrousse B., Guillevin L., Bindi P., Hachulla E., Leclerc P., Gilson B., et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Experimental Rheumatol 11 (1993) 615-621
14. Löwenberg M., Verhaar A.P., van den Brink G.R., and Hommes D.W. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 13 (2007) 158-163
15. Khellaf M., and Godeau B. Pneumocystose au cours des maladies systémiques. Presse Med 38 (2009) 251-259
16. Calderón E.J., Regordan C., Medrano F.J., Ollero M., and Varela J.M. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet 347 (1996) 977
17. Mori S., Cho I., Ichiyasu H., and Sugimoto M. Asymptomatic carriage of Pneumocystis jirovecii in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jirovecii pneumonia during low-dose MTX therapy. Mod Rheumatol 18 (2008) 240-246
18. Morris A., Kingsley L.A., Groner G., Lebedeva I.P., Beard C.B., and Norris K.A. Prevalence and clinical predictors of Pneumocystis colonisation among HIV-infected men. AIDS 18 (2004) 793-798
19. Wakefield A.E., Lindley A.R., Ambrose H.E., Denis C.M., and Miller R.F. Limited asymptomatic carriage of Pneumocystis jirovecii in human immunodeficiency virus-infected patients. J Infect Dis 187 (2003) 901-908